<List><item><source>MED</source><extId>27358174</extId><pmcid>5191969</pmcid><annotations><annotation><prefix>atment;  identifier </prefix><exact>NCT01265498</exact><postfix>,) trial,69 which in</postfix><tags><tag><name>NCT01265498</name><uri>http://identifiers.org/clinicaltrials/NCT01265498</uri></tag></tags><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider></annotation><annotation><prefix>NAFLD ( identifier: </prefix><exact>NCT01999101</exact><postfix>), and the selective</postfix><tags><tag><name>NCT01999101</name><uri>http://identifiers.org/clinicaltrials/NCT01999101</uri></tag></tags><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider></annotation><annotation><prefix>ment (ClinicalTrials.gov identifier: </prefix><exact>NCT00499629</exact><postfix>). </postfix><tags><tag><name>NCT00499629</name><uri>http://identifiers.org/clinicaltrials/NCT00499629</uri></tag></tags><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider></annotation><annotation><prefix>hol in NASH is ongoing ( Identifier: </prefix><exact>NCT02279524</exact><postfix>). </postfix><tags><tag><name>NCT02279524</name><uri>http://identifiers.org/clinicaltrials/NCT02279524</uri></tag></tags><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider></annotation></annotations></item></List>